5 Mainboard IPOs Listed This Week Delivered Outstanding Gains!: The Indian primary market is once again in the news as five prominent companies—Mobikwik Systems, Vishal Mega Mart, Sai Life Sciences, Inventurus Knowledge Solutions (IKS Health), and International Gemological Institute—listed on NSE and BSE this week with solid gains. Even the secondary market was corrected sharply.
Here’s a detailed analysis of their performance and key metrics, alongside a comparative analysis.
Overview of the Five Mainboard IPOs
Mobikwik Systems IPO:
Mobikwik Systems raised Rs 572 crore through a fresh issue of up to 2,05,01,792 equity shares in the price band of Rs 265-279 per share. With a minimum lot size of 53 shares. MobiKwik IPO has been subscribed 119.38 times on the third and final day as the issue received bids for 1,41,72,86,992 shares as against 1.18 crore shares on the offer, according to BSE data.
The retail segment witnessed robust participation, being oversubscribed 134.65 times, while (QIB) was booked 119.50 times, and the portion reserved for Non-Institutional Investors (NII) was booked 108.95 times.
Mobikwik’s strong response translated into a grey market premium (GMP) of Rs 150-155 before listing, signaling potential listing gains of up to 55%.
MobiKwik’s IPO Allotment date was on 16th December 2024 and listed on December 18, 2024, at an impressive gain of 57.71%, opening at Rs 440 against an issue price of Rs 279. Presently MobiKwik’s share price closed at 502.90 on the NSE.
Vishal Mega Mart IPO
Vishal Mega Mart aims to raise Rs 8,000 crore through a fully offer-for-sale (OFS) issue priced between Rs 74-78 per share, with a lot size of 190 shares. The Vishal Mega Mart Ltd IPO was oversubscribed by 28.75 times overall. The retail segment was subscribed 2.43 times, while the non-institutional investor (NII) category saw a subscription of 15.01 times. The qualified institutional buyer (QIB) segment recorded a significant oversubscription of 85.11 times.
Its GMP price was Rs 18-19 before listing, pointing to a 22% potential listing gain. The Vishal Mega Mart shares were listed at a 41% premium on BSE at Rs 110. The Vishal Mega Mart shares closed at Rs 100.75 on NSE last Friday, 20th Dec 2024.
Sai Life Sciences IPO
Sai Life Sciences is targeted at Rs 3,042.6 crore, including a fresh issue of Rs 950 crore, in the price band of Rs 522-549 per share. With a minimum lot size of 27 shares.
The Sai Life Sciences IPO had a subscription rate of 10.27 times by the third day of its offering, according to BSE data. The retail portion of the public issue had been subscribed 1.39 times; the NII segment was booked 4.99 times, whereas the QIB portion received a whopping 29.78 times bidding.
However, the GMP dropped to Rs 18-20 ahead of listing, reflecting muted enthusiasm and listing gains of about 3%. The Sai Life Sciences shares list at Rs 650 on NSE, 18.4% up from the IPO price. The shares closed at Rs 696 on Friday, 20th Dec 2024 above the listed price.
Inventurus Knowledge Solutions (IKS Health) IPO
Inventurus Knowledge Solutions- Rekha Jhunjunwala-backed IPO launched its Rs 2,498 crore IPO with shares priced at Rs 1,265-1,329 per share and a lot size of 11 shares.
Inventurus IPO was subscribed 52.68 times overall, with the public issue receiving 14.55 times subscriptions in the retail category, 80.64 times in the QIB category, and 23.25 times in the NII category as of 6:15:08 PM on 3rd day, December 16, 2024.
The GMP of Rs 375 signals a potential 28% listing gain, though it had earlier peaked at Rs 425 before bidding began. The share price of IKS Health debuted at Rs 1900, a 43% premium over its IPO price. The IKS Health shares closed at Rs 1906 per share on Friday, 20th Dec 2024.
International Gemmological Institute (India) IPO
This Rs 4,225 crore IPO opened on December 13, with a price band of Rs 397-417 per share and a minimum lot size of 35 shares. By the initial bidding period, the issue was subscribed to only 17%, with retail participation at 51% and NIIs at 8%.
But later, the International Gemmological IPO was subscribed 35.48 times overall, with the public issue receiving 11.77 times subscriptions in the retail category, 48.11 times in the QIB category, and 26.09 times in the NII category as of December 17, 2024, the last day.
Despite slower initial traction, the GMP stands at Rs 80-82, suggesting potential gains of 19-20% ahead of the listing price. The diamond grading firm, International Gemmological Institute, debuted on the NSE at ₹510 per share, reflecting a strong premium of 22.30% over its IPO price. The share price of the International Gemological Institute closed at Rs 471.15 per piece on NSE on 20th Dec 2024.
Conclusion
The IPO season presents diverse opportunities for investors, ranging from high-demand offerings like Mobikwik Systems to more cautiously received issues like International Gemmological Institute. While GMP trends hint at listing gains, investors should evaluate each offering’s fundamentals and market conditions before making decisions. With robust participation across segments, these IPOs underscore the growing investor appetite in India’s primary markets.
You may also like to read- BSE and NSE Holidays 2025: A Complete Guide
If you like the post “5 Mainboard IPOs Delivered Outstanding Gains Last Week!” please share it with others.
Happy Investing!
Editor Desk